NASDAQ Stocks
· May 18, 2025 11:30 AM EDT
Not market news
Applied Therapeutics Presents Positive 24-Month Data for Govorestat in CMT-SORD at PNS 2025 Annual Meeting
Clinical trial results show govorestat slows disease progression and reduces sorbitol in CMT-SORD patients over 24 months.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
